Johnson County Clinical Trials

Lenexa, Kansas 66219

2 studies enrolling now · 19 studies all time

What they study most

Body Weight, COVID-19, Cytomegalovirus, Cytomegalovirus Infection, Diarrhea, Healthy, Healthy Participants, Hepatitis B, Herpes Zoster Infection, Human, Influenza, Influenza Infection

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Adults — Running, not enrolling
• A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults — Stopped early
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• A Study of Modified mRNA Vaccines in Healthy Adults — Completed
• Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines — Completed
• A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants — Completed
• Use of Wearable Digital Sensors After mRNA Vaccination in Adults — Completed
• A/H5N1/LT Dose Ranging Study — Completed
• Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults — Completed
• Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant — Completed
• Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch — Completed
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers — Completed
• A Study of the Immune Response to Heplisav in Healthy Older Adults — Completed
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat — Completed
• Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults — Completed
• Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 — Completed
• Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults — Completed